Related Experiment Video
Updated: Aug 22, 2026
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori infection: anything new should we know?
1Department of Medical Microbiology, RF and UCL, Medical School, London, UK.
Abstract:
Over the past year, 2003-4, there have been a number of studies consolidating previous work in relation to pathogenesis of disease, diagnosis and management of Helicobacter pylori. Studies into the pathogenesis of disease have identified the main adhesin of H. pylori as an important virulence marker and as a potential target for therapy. Molecular investigations of both the strain and host variations have identified the action of several of the virulence factors, e.g. cagA, vacA, on disrupting host cell signalling and the consequences in respect of the release of chemokines from the damaged gastric epithelium and the effect on apoptosis. Over the past year, there have been further diagnostic kits developed based on modifications of current technology. Two promising areas of research for diagnosis are the use of host/strain genome polymorphisms as a means of identifying high-risk patients who may develop severe disease and the use of proteomics to identify potential antigens of diagnostic (or therapeutic) use. The three main antibiotics that are used in first-line eradication regimens are clarithromycin, metronidazole and amoxycillin. Of these, metronidazole has the highest prevalence of resistance, followed by clarithromycin; amoxycillin resistance is only rarely reported. The decreasing success of current first-line therapy is the driving force for the development of new antibiotic combinations and a search for novel sources for chemotherapeutic agents and novel therapeutic targets.
Insights
Recent research on Helicobacter pylori focuses on virulence factors for targeted therapy and improved diagnostics. Antibiotic resistance necessitates new treatment strategies for effective H. pylori eradication.
Area of Science:
- Microbiology and Infectious Diseases
- Gastroenterology
- Molecular Biology
Background:
- Helicobacter pylori infection remains a significant global health concern, impacting gastric health.
- Understanding H. pylori pathogenesis, diagnosis, and management is crucial for effective treatment.
- Recent advancements have shed light on virulence factors and host-pathogen interactions.
Purpose of the Study:
- To review recent advancements in H. pylori pathogenesis, diagnosis, and management.
- To highlight novel therapeutic targets and diagnostic approaches.
- To address the growing challenge of antibiotic resistance in H. pylori eradication.
Main Methods:
- Review of recent scientific literature (2003-2004) on H. pylori.
- Analysis of studies on virulence factors (e.g., adhesin, cagA, vacA).
- Evaluation of new diagnostic technologies and antibiotic resistance patterns.
Main Results:
- H. pylori adhesin identified as a key virulence marker and therapeutic target.
- Virulence factors disrupt host cell signaling, leading to chemokine release and apoptosis.
- New diagnostic kits and promising research areas (genome polymorphisms, proteomics) have emerged.
- High resistance rates observed for metronidazole and clarithromycin; amoxicillin resistance is rare.
Conclusions:
- Targeting H. pylori adhesins offers a promising therapeutic avenue.
- Advanced diagnostics, including genomic and proteomic approaches, are vital for personalized risk assessment.
- Decreasing efficacy of current therapies mandates the development of novel antibiotic combinations and therapeutic strategies to combat H. pylori infection.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:27Peptic Ulcer
01:26Gastritis II: Pathophysiology
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:24Peptic Ulcer Disease II: Pathophysiology
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...